One year after the abortion pill became available to Canadian women, new numbers show thousands have used the new option for reproductive health care and sexual health experts say they expect that number to keep rising.

Mifegymiso is the commercial name for a two-drug combination approved by Health Canada to be used to terminate early pregnancies up to nine weeks, which was approved in 2015 with tight restrictions but only became available to the public in January 2017.